Standard precautions: what is meant and what is not

E.T. Curran^*
*NHS National Services Scotland, Health Protection Scotland, UK
Journal of Hospital Infection (2015) 90, 10-11
No abstract.
サマリー原文（英語）はこちら
監訳者コメント：
英国ではカルバペネム分解酵素産生菌の感染対策にからみ、標準予防策とは何かの記載について、WHO と CDC、スコットランド地方の保健当局ならびに英国のエビデンスに基づく感染予防ガイドライン（epic3 プロジェクト）との間で食い違いがあり混乱を招いていると指摘、概念の統一性と今後の進歩に期待を寄せている。

Epidemiology of and risk factors for mortality due to carbapenemase-producing organisms (CPO) in healthcare facilities

S. Zhao*, S. Kennedy, M.R. Perry, J. Wilson, M. Chase-Topping, E. Anderson, M.E.J. Woolhouse, M. Lockhart

*University of Edinburgh, UK

Journal of Hospital Infection (2021) 110, 184-193

Active surveillance for carbapenem-resistant Enterobacteriaceae, vancomycin-resistant enterococci and toxigenic Clostridium difficile among patients transferred from long-term care facilities in Korea

SARS-CoV-2 infection: advocacy for training and social distancing in healthcare settings
A. Gagneux-Brunon^*, C. Pelissier, J. Gagnaire, S. Pillet, B. Pozzetto, E. Botelho-Nevers, P. Berthelot
^*University Hospital of Saint-Etienne, France
Journal of Hospital Infection (2020) 106, 610-612

Surveillance programme for multidrug-resistant bacteria in healthcare-associated infections: an urban perspective in South Brazil

Routine screening for colonization by Gram-negative bacteria in neonates at intensive care units for the prediction of sepsis: systematic review and meta-analysis